This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
This Week In Cannabis: Gaetz's Stock Rally, Major Policy Battles, Homeland Security's Stance, Big Earnings And More Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Big Tobacco's Latest $86.8 Million Cannabis Investment Signals Growing Industry Influence British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
Organigram (OGI) Q1 2025 Earnings Call Transcript OGI earnings call for the period ending December 31, 2024.
DEA Accused Of Bias In Cannabis Rescheduling Hearings: Weed Stocks Plummeted In 2024 As Process Drags On DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Organigram (OGI) Q4 2024 Earnings Call Transcript OGI earnings call for the period ending September 30, 2024.
Cannabis Player Organigram Clocks Q4 Gross Margin Of 37% On Higher Efficiency Across Cultivation And Higher Recreational Sales, Stock Soars Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal Organigram Holdings Inc. (
NASDAQ: OGI ) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in Organigram common shares, based on a 30-day trading VWAP of $2.321 on the TSX. An additional CA$10 million contingent consideration is payable in shares, conditional on achieving a share price above $3.2203 within 12 months. The deal is financed through Organigram's cash reserves.
Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.
Cannabis Stocks Pop Following Chris Christie's Prediction That Trump Will Deschedule Cannabis Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.
Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.
Cannabis Stocks Rally: Canopy, Aurora, SNDL, OrganiGram And Others See Gains Cannabis stocks rally as Canopy Growth, Aurora Cannabis, SNDL, and OrganiGram show positive momentum. We look at resistance levels...
How Germany's Cannabis Market Is Dominating Europe And Unlocking New Profit Opportunities Experts from the Benzinga Cannabis Capital Conference examined the profitability and growth prospects across global marijuana markets.
